Patents Assigned to HALO THERAPEUTICS, LLC.
  • Publication number: 20150086627
    Abstract: Oral and parenteral dosage forms comprising halofuginone, including enteric-coated solid oral dosage forms, subcutaneous dosage forms and intravenous dosage forms, for administration to subjects in need thereof, e.g., subjects having been identified with musculoskeletal disorders, fibrotic diseases, malaria, or cancer are described herein.
    Type: Application
    Filed: March 29, 2013
    Publication date: March 26, 2015
    Applicant: HALO THERAPEUTICS, LLC.
    Inventors: Ernest D. Bush, Diane Mcguire, Marc B. Blaustein